Compound class:
Synthetic organic
Comment: RO7075573 is a macrocyclic peptide with potent antibacterial against carbapenem-resistant Acinetobacter baumannii (CRAB) [2-4]. It is compound 38 claimed in Hoffmann-La Roche's patent WO2017072062A1 [1].
Optimization of this molecular class of compounds led to the development of the clinical candidate zosurabalpin. |
|
Bioactivity Comments |
The MIC for antibacterial activity of RO7075573 is similar for susceptible and multidrug-resistant (MDR) strains of A. baumannii, with a range of 0.06-0.5 μg/ml in vitro [4]. In mouse infection models, RO7075573 was found to be effective in the treatment of infections caused by CRAB however tolerability issues precluded it from further advance [4]. |